Enter a Ticker Symbol To Get Your Free Bull/Bear Rating & Ranking Report from "Stock Scientist" Mike Turner

Dividend Quote

ARPO

Aerpio Pharmaceuticals Inc

Add to Scorecard

New Report from the Award-winning Analyst Who Beat the Market Over 15 Years

(For Privacy Policy visit us here)
*Note: You will not be spammed, ever. Period.

ARPO:Aerpio Pharmaceuticals Inc - Stock Quote and Dividend Data

LATEST CLOSE PRICE

$3.06

EXCHANGE

NASDAQ

SECTOR

Health Care

ARPO
Aerpio Pharmaceuticals Inc Dividend Information
Trailing 12 Month Dividend Yield0.00%
Projected 10 Year Dividend Yield0.00%
Dividend Yield 5 Year Average0.00%
Dividend Rate$0.00
Dividend Payout Ratio0.00%
Dividend Payout Ratio 5 yr Average0.00%
Dividend Growth Rate 3 yr Average0.00%
Dividend Growth Rate 5 yr Average0.00%
Dividend AllStar™ Ranking
Consecutive Dividend Increases0 Years

Dividend Payment TypeNone
Dividend Declaration DateNone
Dividend Ex DateNone
Dividend Record DateNone
Dividend Pay DateNone
Dividend Amount Current$0.000
Dividend Amount Previous$0.000
Dividends Paid in the Last 12 Months0
First Dividend PaidNone

FREE INVESTOR BRIEFING

Collect an 8% Yield on this "Government Mandated Income Opportunity"

(For Privacy Policy visit us here)
*Note: You will not be spammed, ever. Period.
ARPO
Aerpio Pharmaceuticals Inc Stock Information
Latest Close Price$3.06
52-Week Low/High$1.56 - $5.25
Percent Held by Institutions0.00%
Revenue$38,977,239
Net Income$3,424,404
Cash Flow$-6,221,880
EPS0.28%
Market Cap$124,199,280
PE Ratio0
PE Ratio to Industry65%
Debt-Equity Ratio0.00%
Debt-Equity to Industry1.38%
Total Return Last 12 Months-34.19%
Total Return Last 3 Years0.00%
Total Return Last 5 Years0.00%
Latest Trade DateJan. 17, 2019
ARPO
Aerpio Pharmaceuticals Inc Dividend Payment History

No Data available for Payment History.

ARPO
Aerpio Pharmaceuticals Inc Other Details

Aerpio Pharmaceuticals is a biopharmaceutical company focused on treatments for ocular disease. Co.'s main product candidate, AKB-9778, a small molecule activator of the Tie2 pathway, is being developed for the treatment of diabetic retinopathy. In addition, Co. has two pipeline programs. AKB-4924 is a drug candidate for the treatment of inflammatory bowel disease and ARP-1536, humanized monoclonal antibody is a drug candidate for ocular disease. Humanized antibodies are antibodies from non-human species whose protein sequences have been modified to increase their similarity to antibodies produced naturally in humans.

Web Sitewww.aerpio.com
SectorHealth Care
SegmentPharmaceuticals & Biotechnology
IndustryPharmaceuticals
Dividend AllStar™ Ranking
Dividend Re-Investment PlanNo
Re-Investment AgentNone
Direct Purchase Minimum$0
Optional Cash Pay Min-Max$0 - $0
Optional Cash Payment FrequencyNone
Dividend Tools

Building a successful dividend income portfolio is simple… if you have the right tools at your disposal. Here’s a sampling of Dividend Investor’s Dividend Tools, used by thousands of investors across the globe to gain a substantial edge in their portfolio strategies.

Dividend AllStar™ Ranking

Find stocks with consecutively increasing dividends:

  • = 5 years of dividend increases
  • = 10 years of dividend increases
  • = 20 years of dividend increases

Click to Learn More

Monthly Dividend Directory

Learn which investments pay out every month, including:

  • Dividend yield
  • Ex-dividend date
  • Dividend payout date… and more

Click to Learn More

Stock Screening Tools

Screen and filter thousands of dividend-paying investments with Dividend Investor’s advanced screening tools:

  • Dividend Payout Ratio
  • Consecutive Increases
  • 5-Year Total Return… and more

Click to Learn More

Try Dividend Investor PREMIUM for as low as $29

  • Dividend Allstars™ Tool
  • Proprietary Ex-dividend Calendar
  • Dividend Scorecard™ Portfolio Tracker
  • Customized Dividend Stock Screener
  • 4 FREE special reports from leading dividend experts
  • And much more...
 
Aerpio Pharmaceuticals Inc Dividend Stock News and Updates

Jan. 12, 2019CLOSE PRICE INCREASE: Aerpio Pharmaceuticals Inc (NASDAQ: ARPO) on 01-12-2019 increased close price > 10% from $2.40 to $3.00

Read more...

Jan. 09, 2019CLOSE PRICE INCREASE: Aerpio Pharmaceuticals Inc (NASDAQ: ARPO) on 01-09-2019 increased close price > 10% from $2.13 to $2.40

Read more...

Jan. 03, 2019CLOSE PRICE INCREASE: Aerpio Pharmaceuticals Inc (NASDAQ: ARPO) on 01-03-2019 increased close price > 10% from $1.70 to $1.99

Read more...
More Aerpio Pharmaceuticals Inc Dividend News
Pharmaceuticals Dividend Stock News and Updates

Jan. 18, 2019CLOSE PRICE DECREASE: Acura Pharmaceuticals Inc (OTCBB: ACUR) on 01-18-2019 decreased close price > 10% from $0.18 to $0.13

Read more...

Jan. 18, 2019CLOSE PRICE INCREASE: Fountain Healthy Aging, Inc. (OTCBB: FHAI) on 01-18-2019 increased close price > 10% from $0.00 to $0.00

Read more...

Jan. 18, 2019CLOSE PRICE INCREASE: Com Par$/Generex Biotechnology Corp (DE) (OTCBB: GNBT) on 01-18-2019 increased close price > 10% from $2.54 to $2.97

Read more...
More Pharmaceuticals Dividend News
X

Search Dividend Investor